Literature DB >> 9323027

Selection and identification of single domain antibody fragments from camel heavy-chain antibodies.

M Arbabi Ghahroudi1, A Desmyter, L Wyns, R Hamers, S Muyldermans.   

Abstract

Functional heavy-chain gamma-immunoglobulins lacking light chains occur naturally in Camelidae. We now show the feasibility of immunising a dromedary, cloning the repertoire of the variable domains of its heavy-chain antibodies and panning, leading to the successful identification of minimum sized antigen binders. The recombinant binders are expressed well in E. coli, extremely stable, highly soluble, and react specifically and with high affinity to the antigens. This approach can be viewed as a general route to obtain small binders with favourable characteristics and valuable perspectives as modular building blocks to manufacture multispecific or multifunctional chimaeric proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323027     DOI: 10.1016/s0014-5793(97)01062-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  214 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

2.  Single-domain antibody fragments with high conformational stability.

Authors:  Mireille Dumoulin; Katja Conrath; Annemie Van Meirhaeghe; Filip Meersman; Karel Heremans; Leon G J Frenken; Serge Muyldermans; Lode Wyns; Andre Matagne
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

3.  Heavy-chain only antibodies derived from dromedary are secreted and displayed by mouse B cells.

Authors:  Viet Khong Nguyen; Xiangang Zou; Marc Lauwereys; Lea Brys; Marianne Brüggemann; Serge Muyldermans
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

4.  Isolation of alpaca anti-hapten heavy chain single domain antibodies for development of sensitive immunoassay.

Authors:  Hee-Joo Kim; Mark R McCoy; Zuzana Majkova; Julie E Dechant; Shirley J Gee; Sofia Tabares-da Rosa; Gualberto G González-Sapienza; Bruce D Hammock
Journal:  Anal Chem       Date:  2011-12-29       Impact factor: 6.986

Review 5.  Recombinant antibodies for the diagnosis and treatment of cancer.

Authors:  Jürgen Krauss
Journal:  Mol Biotechnol       Date:  2003-09       Impact factor: 2.695

Review 6.  The production and application of single-chain antibody fragments.

Authors:  D Blazek; V Celer
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

7.  Dual beneficial effect of interloop disulfide bond for single domain antibody fragments.

Authors:  Jochen Govaert; Mireille Pellis; Nick Deschacht; Cécile Vincke; Katja Conrath; Serge Muyldermans; Dirk Saerens
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

8.  Preparation of unnatural N-to-N and C-to-C protein fusions.

Authors:  Martin D Witte; Juan J Cragnolini; Stephanie K Dougan; Nicholas C Yoder; Maximilian W Popp; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

9.  Llama-derived single-domain antibodies for the detection of botulinum A neurotoxin.

Authors:  Marla D Swain; George P Anderson; Dan Zabetakis; Rachael D Bernstein; Jinny L Liu; Laura J Sherwood; Andrew Hayhurst; Ellen R Goldman
Journal:  Anal Bioanal Chem       Date:  2010-06-28       Impact factor: 4.142

10.  Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.

Authors:  Jens De Vos; Iris Mathijs; Catarina Xavier; Sam Massa; Ulrich Wernery; Luc Bouwens; Tony Lahoutte; Serge Muyldermans; Nick Devoogdt
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.